danazol has been researched along with Angioedema, Hereditary, Type I in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cervenak, L; Farkas, H; Kajdácsi, E; Karádi, I; Kőhalmi, KV; Nebenführer, Z; Szabó, E; Zsáry, A | 1 |
Hide, M; Iwamoto, K; Shibuya, M; Takahashi, N; Yabe, M | 1 |
Chen, YJ; Kao, YH; Lei, WT; Shyur, SD | 1 |
Bergman, W; Lavrijsen, AP; van Kester, MS | 1 |
Csuka, D; Czaller, I; Farkas, H; Imreh, É; Takács, E; Varga, L; Veszeli, N; Zotter, Z | 1 |
Abalkhail, HA; Al-Abdulatif, A; Al-Dayel, F; Al-Gazlan, S; Faiyaz-Ul-Haque, M; Khaliq, AM; Peltekova, I; Toulimat, M; Zaidi, SH | 1 |
Späth, P; Steiner, U; Wais-Nöcker, B; Wuillemin, WA | 1 |
Firszt, R; Frank, MM | 1 |
Bors, A; Csuka, D; Czaller, I; Farkas, H; Füst, G; Kelemen, Z; Miklós, K; Molnár, K; Rajczy, K; Szabó, Z; Varga, L | 1 |
Csuka, D; Farkas, H; Kőszegi, L; Tóth, F; Varga, L | 1 |
Csuka, D; Farkas, H; Harmat, G; Jakab, L; Karádi, I; Nébenfűhrer, Z; Szabó, E; Temesszentandrási, G; Varga, L; Zotter, Z | 1 |
Berlin, N; Chan, W; Sussman, GL | 1 |
1 review(s) available for danazol and Angioedema, Hereditary, Type I
Article | Year |
---|---|
An overview of novel therapies for acute hereditary angioedema.
Topics: Acute Disease; Adrenergic beta-Antagonists; Androgens; Antifibrinolytic Agents; Bradykinin; Bradykinin Receptor Antagonists; Complement C1 Inhibitor Protein; Danazol; Hereditary Angioedema Type III; Hereditary Angioedema Types I and II; Hormone Antagonists; Humans; Kallikreins; Peptides; Tranexamic Acid | 2010 |
11 other study(ies) available for danazol and Angioedema, Hereditary, Type I
Article | Year |
---|---|
Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
Topics: Adult; Atherosclerosis; Bradykinin; Case-Control Studies; Complement C1 Inhibitor Protein; Danazol; Disease Progression; Endothelial Cells; Endothelium, Vascular; Estrogen Antagonists; Female; Hereditary Angioedema Types I and II; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Surveys and Questionnaires; Vasodilation; Young Adult | 2019 |
Hereditary angioedema as the cause of death from asphyxia: postmortem computed tomography study.
Topics: Adult; Airway Obstruction; Asphyxia; Cause of Death; Complement C1 Inhibitor Protein; Danazol; Fatal Outcome; Hereditary Angioedema Types I and II; Humans; Male; Nigeria; Pharynx; Sequence Deletion; Tomography, X-Ray Computed; Young Adult | 2014 |
Type II hereditary angioedema: The first case report in Taiwan.
Topics: Abdomen; Adult; Complement C1 Inhibitor Protein; Danazol; Estrogen Antagonists; Hereditary Angioedema Types I and II; Humans; Male; Taiwan; Tomography, X-Ray Computed | 2016 |
A Female with Hereditary Angioedema Developing Wheals: A Case Report.
Topics: Antifibrinolytic Agents; Cetirizine; Danazol; Estrogen Antagonists; Female; Hereditary Angioedema Types I and II; Histamine H1 Antagonists, Non-Sedating; Humans; Middle Aged; Tranexamic Acid | 2017 |
Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Biomarkers; Case-Control Studies; Complement C1 Inhibitor Protein; Complement C4; Complement System Proteins; Danazol; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hereditary Angioedema Types I and II; Humans; Male; Middle Aged; Thyroid Hormones; Young Adult | 2016 |
Novel and recurrent mutations in the C1NH gene of Arab patients affected with hereditary angioedema.
Topics: Adolescent; Adult; Aged; Arabs; Child; Child, Preschool; Codon, Nonsense; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Complement C3; Complement C4; Danazol; Female; Hereditary Angioedema Types I and II; Humans; Male; Middle Aged; Middle East; Mutation, Missense; Pedigree; Young Adult | 2010 |
[Clinical facets of hereditary angioedema among Swiss patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Child; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Delayed Diagnosis; Estrogen Antagonists; Female; Hereditary Angioedema Types I and II; Humans; Infusions, Intravenous; Male; Medical History Taking; Middle Aged; Risk Factors; Tranexamic Acid; Young Adult | 2010 |
Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?
Topics: Adolescent; Adult; Aged; Autoantibodies; Celiac Disease; Child; Cohort Studies; Comorbidity; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Diet, Gluten-Free; Female; Hereditary Angioedema Types I and II; Humans; Immunoglobulin A; Immunoglobulin G; Male; Mass Screening; Middle Aged; Prevalence; Transglutaminases; Treatment Outcome; Young Adult | 2011 |
Successful pregnancy outcome after treatment with C1-inhibitor concentrate in a patient with hereditary angioedema and a history of four miscarriages.
Topics: Abortion, Habitual; Adult; Complement C1 Inhibitor Protein; Danazol; Female; Hereditary Angioedema Types I and II; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Tranexamic Acid | 2012 |
Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Complement C1 Inhibitor Protein; Danazol; Female; Follow-Up Studies; Hereditary Angioedema Types I and II; Humans; Male; Middle Aged; Retrospective Studies; Tranexamic Acid; Treatment Outcome; Young Adult | 2012 |
Management of hereditary angioedema with C1-inhibitor concentrate during two successive pregnancies.
Topics: Adolescent; Adult; Complement C1 Inhibitor Protein; Complement Inactivating Agents; Danazol; Estrogen Antagonists; Female; Hereditary Angioedema Types I and II; Humans; Pregnancy; Pregnancy Complications, Cardiovascular | 2013 |